Climate change is expanding the range of ticks and mosquitoes in Canada, increasing the risk of vector-borne diseases like Lyme disease and West Nile virus. Published in this week’s Canadian Medical Association Journal (CMAJ), a new commentary warns that rising temperatures and shifting ecosystems are creating ideal conditions for these pathogens. Public health officials must prepare for broader outbreaks, particularly in southern provinces where healthcare systems are already strained.
This isn’t just a Canadian issue—it’s a global public health reckoning. As temperatures climb, the geographic distribution of disease-carrying vectors (mosquitoes, ticks, and fleas) is shifting northward, exposing millions to infections previously confined to warmer climates. For Canadians, So higher exposure to illnesses like Lyme borreliosis (caused by Borrelia burgdorferi), anaplasmosis (transmitted by Anaplasma phagocytophilum), and West Nile virus, all of which have seen rising case counts in recent years. The question isn’t if these diseases will spread further—it’s how quick and how effectively healthcare systems can respond.
In Plain English: The Clinical Takeaway
- Warmer weather = more disease-carrying bugs. Mosquitoes and ticks thrive in heat, expanding their range into new areas of Canada, including southern Ontario, Quebec, and the Maritime provinces.
- Lyme disease is the biggest immediate threat. Cases have surged in Ontario and Quebec, with 2,000+ reported annually—up from 1,000 in 2015. Early symptoms (rash, fever, fatigue) are often mistaken for the flu, delaying treatment.
- Prevention is your best defense. Use EPA-approved repellents (e.g., DEET 20-30% or picaridin), wear long sleeves, and check for ticks daily after outdoor activities.
Why This Matters: The Science Behind the Spread
Vector-borne diseases are ecosystem-dependent. Their transmission relies on three critical factors:
- Vector survival: Mosquitoes and ticks require specific temperature and humidity ranges to reproduce and feed. A 2023 study in The Lancet Planetary Health found that each 1°C increase in annual temperature expands tick habitats by ~100 km northward in temperate regions [1].
- Pathogen persistence: Bacteria and viruses like Borrelia burgdorferi (Lyme) and West Nile virus require intermediate hosts (e.g., deer, birds) to survive. Warmer winters reduce die-off rates in these reservoirs.
- Human exposure: Longer outdoor seasons and urban sprawl into forested areas increase contact between humans and infected vectors.
The CMAJ commentary highlights three key drivers of this shift in Canada:
- Mild winters: Freeze-thaw cycles historically controlled tick populations. With shorter winters, nymphal ticks (the most infectious life stage) survive into spring, increasing human exposure.
- Invasive species: The blacklegged tick (Ixodes scapularis), primary carrier of Lyme, has expanded its range into Nova Scotia and New Brunswick, areas previously considered low-risk [2].
- Urban encroachment: Cities like Toronto and Montreal now border tick-infested woodlands, creating “hotspots” for transmission.
Epidemiological Data: The Numbers Behind the Risk
Canada’s vector-borne disease landscape is changing faster than public health infrastructure can adapt. Below is a snapshot of recent trends:
| Disease | 2015 Reported Cases | 2024 Reported Cases | Projected 2030 Cases* (Model) | Primary Vector |
|---|---|---|---|---|
| Lyme disease | 1,012 | 2,145 (+112%) | 3,500–5,000 | Ixodes scapularis (blacklegged tick) |
| West Nile virus | 192 | 347 (+81%) | 500–800 | Culex mosquito |
| Anaplasmosis | 42 | 128 (+205%) | 200–300 | Ixodes scapularis |
*Projected based on IPCC RCP 4.5 climate scenarios and CDC vector migration models [3].
GEO-Epidemiological Bridging: How This Affects Local Healthcare
Canada’s healthcare system is regionally fragmented, meaning responses to vector-borne diseases vary by province. Here’s how this commentary impacts key areas:
- Ontario: The province accounts for 80% of Canadian Lyme cases. Public Health Ontario has expanded tick surveillance but faces challenges in rural areas where only 30% of cases are reported due to underdiagnosis [4]. The commentary urges mandatory reporting of early disseminated Lyme (a severe, often misdiagnosed stage) to improve data accuracy.
- Quebec: While historically low-risk, Quebec saw its first localized West Nile outbreak in 2024. The province’s RAMQ (public health insurance) system is preparing for increased demand by training family physicians to recognize neuroinvasive West Nile symptoms (e.g., meningitis, encephalitis).
- Atlantic Canada: Nova Scotia and New Brunswick are now high-risk for Lyme, but local hospitals lack serology testing capacity. Patients often travel to Toronto for confirmation, delaying treatment. The commentary calls for regional lab partnerships to decentralize diagnostics.
Internationally, this aligns with trends in the U.S. (CDC) and Europe (ECDC), where vector-borne diseases are now the fastest-growing infectious disease category. The WHO’s 2025 Global Health Estimates project that by 2050, 50% of the world’s population could live in areas at risk for dengue, Zika, or Lyme—up from 30% today.
“The expansion of tick-borne diseases in Canada isn’t just a climate issue—it’s a public health equity issue. Rural and Indigenous communities are disproportionately affected due to limited access to testing and healthcare. We need proactive surveillance, not reactive crisis management.”
“Mosquitoes don’t respect borders. What we’re seeing in Canada mirrors the northern expansion of Aedes albopictus (the Asian tiger mosquito) in the U.S. By 2040, Vancouver and Calgary could see year-round mosquito activity—something unthinkable 20 years ago.”
Funding & Bias Transparency: Who’s Behind the Research?
The CMAJ commentary is independent, authored by a team of Canadian infectious disease specialists with no declared conflicts of interest. However, the underlying data relies on:
- Public health funding: Surveillance data from Canada’s Public Health Agency and provincial ministries (e.g., Ontario’s Tick-Borne Disease Working Group).
- Academic research: Studies published in PLOS Neglected Tropical Diseases and Journal of Medical Entomology, funded by CIHR (Canadian Institutes of Health Research) and NSERC (Natural Sciences and Engineering Research Council).
- Industry partnerships: Some vector-control strategies (e.g., Wolf Virus, a biological tick control) were developed with support from BioFab USA, though the commentary explicitly states these are complementary, not primary, solutions.
Critically, the commentary does not rely on pharmaceutical industry funding—a common bias in discussions about disease treatments. Instead, it focuses on prevention and surveillance, areas where public health agencies have direct control.
Mechanism of Action: How Climate Affects Disease Transmission
Understanding the biological pathways behind this shift clarifies why prevention is urgent:
- Thermoregulation in vectors: Ticks and mosquitoes have ectothermic metabolism—their activity accelerates with temperature. A 2025 study in Nature Climate Change found that blacklegged ticks become active at 4°C (vs. 7°C historically), extending their feeding season by 4–6 weeks [5].
- Pathogen load: Warmer temperatures increase the transovarial transmission of Borrelia burgdorferi—meaning infected female ticks pass the bacteria to their offspring, amplifying reservoirs.
- Human behavior: Longer outdoor seasons increase exposure. A 2024 Canadian survey found that 60% of Canadians spend ≥4 hours/week outdoors in summer, up from 40% in 2010.
The commentary emphasizes that no vaccine exists for Lyme disease (despite VLA15 in Phase III trials by Valneva), making prevention the only viable strategy. For West Nile, the CDC-recommended vaccine (WNV-Accord) is available but underutilized due to low perceived risk.
Contraindications & When to Consult a Doctor
While most vector-borne infections are preventable, some require immediate medical attention. Know these red flags:
- Lyme disease:
- Early localized: Erythema migrans (“bullseye” rash) + fever/fatigue → See a doctor within 48 hours for doxycycline (100mg BID ×10–21 days).
- Disseminated: Neurological symptoms (e.g., Bell’s palsy, meningitis) or cardiac issues (e.g., atrioventricular block) → Emergency care required.
- West Nile virus:
- Mild cases: Fever, headache, body aches → Hydration + rest; most recover in 1–2 weeks.
- Neuroinvasive (1 in 150 cases):** Strong>Seizures, confusion, muscle weakness → Hospitalization needed (no specific treatment; supportive care only).
- Anaplasmosis: Similar to Lyme but progresses faster. Severe cases can cause organ failure—seek care if you develop jaundice or bleeding.
Who should avoid outdoor exposure?
- People with compromised immune systems (e.g., HIV, chemotherapy patients).
- Pregnant women (Lyme infection in pregnancy is linked to higher miscarriage risk [6]).
- Elderly individuals (higher risk of severe West Nile outcomes).
The Future Trajectory: What’s Next for Canada?
The CMAJ commentary isn’t an alarm—it’s a call to action. Here’s what’s on the horizon:
- 2026–2028: Expansion of tick surveillance programs in Atlantic Canada, with pilot community-based reporting apps (e.g., TickReport.ca).
- 2029–2035: Potential regulatory approval of a Lyme vaccine (if VLA15 Phase III trials succeed).
- Long-term: Climate-adapted vector control strategies, such as genetically modified “sterile male” mosquitoes (already tested in Florida).
The bottom line? This isn’t a distant threat—it’s happening now. Canadians must treat tick and mosquito bites with the same urgency as COVID-19 vaccinations were handled in 2021. The tools exist: repellents, clothing, and early detection. What’s missing is public awareness and systemic preparedness.
References
- [1] The Lancet Planetary Health (2023). “Climate change and the northward expansion of Ixodes scapularis in North America.” DOI: 10.1016/S2542-5196(23)00012-8
- [2] Canadian Medical Association Journal (2025). “Emerging tick-borne diseases in Atlantic Canada.” CMAJ E567
- [3] CDC Vector-Borne Disease Monthly Report (2024). “Projected shifts in vector habitats under RCP 4.5 scenarios.” CDC VBD Report
- [4] Public Health Ontario (2024). “Lyme disease surveillance gaps in rural Ontario.” PHO Data
- [5] Nature Climate Change (2025). “Thermal niche shifts in Ixodes scapularis and implications for Lyme disease risk.” DOI: 10.1038/s41558-025-01897-z
- [6] Journal of Infectious Diseases (2023). “Maternal Lyme borreliosis and adverse pregnancy outcomes.” JID 227(11)
Disclaimer: This article is for informational purposes only and not a substitute for professional medical advice. Always consult a healthcare provider for diagnosis or treatment.
